Back to TWO SIGMA ADVISERS, LP TWO SIGMA ADVISERS, LP

EGRXEGRX
Showing 2 of 16 quarters

Position history for TWO SIGMA ADVISERS, LPTWO SIGMA ADVISERS, LP's holdings in EAGLE PHARMACEUTICALS INC

No. Two Sigma exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 185,058 shares worth $690,266. Two Sigma first reported EGRX in Q1 2019 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$690,266

Total Shares Change

-185,058

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
185,058
-17.7%
$690,2660.0%$3.95
0

Other major holders of EGRX: BNP PARIBAS FINANCIAL MARKETS, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used